News

Keep up to date with CTx announcements, press releases and general news items

By CTxadmin
 • 
2 years ago

Cancer Therapeutics CRC (CTx) is proud to announce that it received the Australian CRC Association’s (CRCA) Award for Excellence in Innovation at the annual awards dinner in Canberra on 24 May. The award is in recognition of CTx’s discovery and development of novel oncology drug candidates …
Read More

By CTxadmin
 • 
3 years ago

The Victorian Comprehensive Cancer Council has announced a new Executive Director to lead the organisation from 3 April 2017. After an international search, Australian clinician-scientist, Professor Grant McArthur, was appointed to the role.

Professor McArthur, is a familiar face within cancer research, and as well …
Read More

By CTxadmin
 • 
3 years ago
By CTxadmin
 • 
3 years ago

Minister for Small Business, Innovation and Trade Philip Dalidakis officially launched the STEMM (Science, Technology, Engineering, Mathematics and Medicine) Bootcamp in Melbourne today, which will give Victoria’s biomedical researchers a competitive edge.

STEMM Bootcamp is a collaborative project spearheaded …
Read More

By CTxadmin
 • 
3 years ago

CTx Chief Executive, Dr. Warwick Tong, today announced that a majority of its current partners have chosen to reinvest their share of the recent cash distribution from CTx back into the organisation.

In January 2016 CTx licensed its PRMT5 Project to MSD (known as Merck …
Read More

By CTxadmin
 • 
3 years ago

Australian drug development company Bionomics Limited (ASX:BNO, OTCQX:BNOEF) has received US$736,815 in licensing funds as part of an agreement between MSD (known as Merck in the US & Canada) and Cancer Research Technologies (CRT) on behalf of the Australian Cooperative Research Centre for Cancer Therapeutics …
Read More